How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
How does emerging patent case law in the US and Europe affect precision medicine? How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI? / Aboy, Mateo; Cohen, Glenn ; Liddell, Kathleen; Liddicoat, Johnathan; Crespo, Cristina; Gerke, Sara; Minssen, Timo.
In: Nature Biotechnology, Vol. 37, No. 10, 02.10.2019, p. 1118–1125.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - How does emerging patent case law in the US and Europe affect precision medicine?
T2 - How will today’s patent law affect tomorrow’s innovation in the areas of biomarkers and nature-based products; diagnostics; and algorithms, big data and AI?
AU - Aboy, Mateo
AU - Cohen, Glenn
AU - Liddell, Kathleen
AU - Liddicoat, Johnathan
AU - Crespo, Cristina
AU - Gerke, Sara
AU - Minssen, Timo
PY - 2019/10/2
Y1 - 2019/10/2
N2 - Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future ofprecision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine: (1) biomarkers and nature-based products; (2) diagnostics; and (3) algorithms, big data, and AI. We explain how today’s law will affect tomorrow’s innovation.
AB - Precision medicine has stirred the excitement of patients, physicians, industry, entrepreneurs, and investors — it is already a market that is worth tens of billions of dollars with very rapid growth expected. But the future ofprecision medicine heavily depends on the intellectual property frameworks that apply to its various forms. In order to chart this future, we compare recent patent case law in the US and Europe in three areas of precision medicine: (1) biomarkers and nature-based products; (2) diagnostics; and (3) algorithms, big data, and AI. We explain how today’s law will affect tomorrow’s innovation.
KW - Faculty of Law
KW - pecision medicine
KW - patents
KW - Biomarkers
KW - diagnostics
KW - Artificial intelligence
KW - big data
KW - algorithm engineering
UR - https://rdcu.be/bSLBa
UR - https://www.nature.com/articles/s41587-019-0265-1
U2 - 10.1038/s41587-019-0265-1
DO - 10.1038/s41587-019-0265-1
M3 - Journal article
C2 - 31578504
VL - 37
SP - 1118
EP - 1125
JO - Nature Biotechnology
JF - Nature Biotechnology
SN - 1087-0156
IS - 10
ER -
ID: 213793813